INTEGRATED BIOPHARMA INC Quarterly Common Stock, Shares, Outstanding from Q2 2011 to Q1 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Integrated Biopharma Inc quarterly Common Stock, Shares, Outstanding history and growth rate from Q2 2011 to Q1 2024.
  • Integrated Biopharma Inc Common Stock, Shares, Outstanding for the quarter ending March 31, 2024 was 30.1M shares, a 0.5% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 30.1M +150K +0.5% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 30.1M +150K +0.5% Dec 31, 2023 10-Q 2024-02-12
Q3 2023 30.1M +150K +0.5% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 29.9M 0 0% Jun 30, 2023 10-Q 2024-05-10
Q1 2023 29.9M +117K +0.39% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 29.9M +118K +0.39% Dec 31, 2022 10-Q 2023-02-10
Q3 2022 29.9M +129K +0.43% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 29.9M +146K +0.49% Jun 30, 2022 10-K 2023-09-15
Q1 2022 29.8M +85.3K +0.29% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 29.8M +151K +0.51% Dec 31, 2021 10-Q 2022-02-10
Q3 2021 29.8M +174K +0.59% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 29.8M +157K +0.53% Jun 30, 2021 10-K 2022-09-13
Q1 2021 29.7M +182K +0.62% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 29.7M +115K +0.39% Dec 31, 2020 10-Q 2021-02-12
Q3 2020 29.6M +80K +0.27% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 29.6M +80K +0.27% Jun 30, 2020 10-K 2021-09-02
Q1 2020 29.6M 0 0% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 29.6M 0 0% Dec 31, 2019 10-Q 2020-02-12
Q3 2019 29.6M +200K +0.68% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 29.6M +8.43M +39.9% Jun 30, 2019 10-K 2020-09-23
Q1 2019 29.6M +8.4M +39.7% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 29.6M +8.4M +39.7% Dec 31, 2018 10-Q 2019-02-13
Q3 2018 29.4M +8.2M +38.7% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 21.1M 0 0% Jun 30, 2018 10-K 2019-08-29
Q1 2018 21.2M +39.9K +0.19% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 21.2M +59.9K +0.28% Dec 31, 2017 10-Q 2018-02-09
Q3 2017 21.2M +64.9K +0.31% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 21.1M +30K +0.14% Jun 30, 2017 10-K 2018-09-12
Q1 2017 21.1M -9.9K -0.05% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 21.1M +5K +0.02% Dec 31, 2016 10-Q 2017-02-10
Q3 2016 21.1M 0 0% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 21.1M 0 0% Jun 30, 2016 10-K 2017-09-01
Q1 2016 21.1M +34.9K +0.17% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 21.1M -34.9K -0.17% Dec 31, 2015 10-Q 2016-02-19
Q3 2015 21.1M 0 0% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 21.1M 0 0% Jun 30, 2015 10-K 2016-09-02
Q1 2015 21.1M -9.9K -0.05% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 21.1M +25K +0.12% Dec 31, 2014 10-Q 2015-02-17
Q3 2014 21.1M -9.9K -0.05% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 21.1M +25K +0.12% Jun 30, 2014 10-K 2015-09-04
Q1 2014 21.1M 0 0% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 21.1M 0 0% Dec 31, 2013 10-Q/A 2014-02-13
Q3 2013 21.1M 0 0% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 21.1M 0 0% Jun 30, 2013 10-K 2014-09-08
Q1 2013 21.1M +84.9K +0.4% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 21.1M +135K +0.64% Dec 31, 2012 10-Q 2013-02-19
Q3 2012 21.1M +185K +0.88% Sep 30, 2012 10-Q 2012-11-19
Q2 2012 21.1M +200K +0.96% Jun 30, 2012 10-K 2013-09-30
Q1 2012 21M Mar 31, 2012 10-Q 2012-05-21
Q4 2011 21M Dec 31, 2011 10-Q 2012-02-21
Q3 2011 20.9M Sep 30, 2011 10-Q 2011-11-21
Q2 2011 20.9M Jun 30, 2011 10-K 2012-10-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.